James M. Frincke, CEO at Harbor BioSciences, Inc. (HRBR), bought 25,000 shares at $0.13 ($3K) on 2011-10-18, disclosed to the SEC on 2011-10-21.
Open-market purchase of $3k HRBR by CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |